U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

Prince Harry's visa status in the US faces scrutiny under the Trump administration. Judge Carl J. Nichols has ordered court hearings over allegations ...

The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...

The accused drug smuggler is to be extradited to NSW after he was arrested on a yacht on Australia Day allegedly trying to ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

The former UK Home Secretary weighed in behind the American think-tank as it prepares for the first court hearing for the ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

A GB News host has commented on Suella Braverman 'calling on' Donald Trump to release Prince Harry's visa records.